Preventative Med in Adults Flashcards
Primary prevention
remove/reduce disease risk factors; e.g., immunization, giving up or not starting smoking
Secondary prevention:
promote early detection of disease or precursor states e.g., routine cervical pap smear
Tertiary prevention
limiting impact of established disease e. g., partial mastectomy and RT to remove and control localized breast cancer
Requirements of an Effective Screening Test
- Disease is an important cause of morbidity and mortality
- Screening can detect disease in early, pre symptomatic phase
- Screening and treating patients with early disease or risk factors produces better health outcomes than treating patients when they present with symptoms
- Screening test is acceptable to patients and clinicians - safe, convenient, acceptable false-positive rate, acceptable costs
- Benefits of early detection and treatment are sufficient to justify potential harms and costs of screening
USPSTF Grading System (prior to May 2007)
A: Strongly recommended
B: Recommended
C: No recommendation: fair evidence it can improve health outcomes, but balance of benefit and harm too close to make general recommendation
D: Not recommended-fair evidence of ineffectiveness, or harm outweighs benefits
I: Insufficient data to recommend for or against
Hypertension screening
all persons >18 (A)
Height/weight screening
all persons: If BMI> 30, offer counseling: AAFP
Screen children over the age of 6
Lipid Disorders screening
screen all men >35 and women >45 (A)
- screen men 20-35 who are at risk (B) - screen women 20-45 who are at risk (B)
Chlamydia-
- all sexually active non-pregnant women ≤ 24 (A)
- all older non-pregnant women at increased risk (A),
- all pregnant women ≤ 24 and older pregnant women of increased risk (B)
- No screening for men (I)
Syphilis
screen all persons at increased risk for syphilis (A)
-screen all pregnant women (A)
Bone density screening
women >65 at high risk for osteoporosis (B)
-Women > 65 without a previously known fracture, or secondary cause of osteoporosis
-Screen women than that of a 65 y/o white woman
without other risk factors (B)
Colorectal cancer
screen all persons with fecal occult blood testing (FOBT), sigmoidoscopy or colonoscopy > 50 and up to age 75 (A)
Prostate Cancer screening: USPSTF
USPSTF recommends AGAINST PSA-based screening for prostate cancer (D)
American Urologic Society, 2013 Guidelines:
-No PSA in men < 40
-No PSA in men at average risk, 40-54 years old
-In men 55-69, PSA screening based on “shared decision-making”
-In men over 70, no screening
If screening, PSA and digital rectal exam (DRE) are complimentary
USPSTF Breast cancer screening
biennial screening mammogram women 50-74(B)
Cervical cancer screening: USPSTF recommendations:
Women ages 21-65 with Pap every 3 years
Women ages 30-65 who want to lengthen the screening interval-screen with
a combination of cytology and human papilloma virus (HPV) testing every 5 years (A)
USPSTF recs for screening for Abdominal Aortic Aneurysm
Men 65-75 who have ever smoked (B)
Women 65-75: do not screen (D)
Lung cancer screening: National Lung Screening Trial (NLST)
USPSTF
Recommending low-dose spiral (helical) CT in the following:
-high risk: > 55, smoked >30 pack years (unless has quit 15+ years)
> 50, smoked >20 pack years + one other risk factor
-No screening recommended in mod/low risk patients
Moderate risk > 50, >20 pack years or 2nd hand smoke, no other risk factors
Low risk: < 50, non-smoker
ALL patients should be asked about tobacco and tobacco product use, and counseled appropriately
Hypertension (high blood pressure)
Screening every 2 yrs with BP < 120/80
Screening every year with systolic blood pressure 120-139 or diastolic blood pressure 80-90
Type 2 diabetes (B)
Adults with sustained BP >135/80: perform fasting glucose, 2-hr post-load glucose,
HgA1C
ADA recommends FBS, and if FBS > 126 mg/dl, =DM; needs confirmatory testing